ZIDOVUDINE ADHERENCE AMONG INDIVIDUALS WITH HIV-INFECTION

被引:103
|
作者
MUMA, RD
ROSS, MW
PARCEL, GS
POLLARD, RB
机构
[1] UNIV TEXAS,HLTH SCI CTR,SCH PUBL HLTH,HOUSTON,TX
[2] UNIV TEXAS,MED BRANCH,SCH MED,GALVESTON,TX 77550
关键词
D O I
10.1080/09540129550126399
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The objective was to investigate the relationships among health beliefs, attitudes, and zidovudine compliance in individuals with HIV infection. A survey was administered to 52 individuals with HIV infection. The survey items, which reflected concerns expressed about zidovudine, were generated based on barriers to and benefits of zidovudine and the perceived susceptibility to and perceived severity of HIV as described by the health belief model (HEM). These items were expressed as attitudes and beliefs. Items were subjected to factor analysis, and survey results were correlated with laboratory data to predict adherence to their prescribed medication-taking regimen. Data indicated that 42.3% of the subjects were compliant with zidovudine. Factor analysis identified four dimensions: problems taking and scepticism about zidovudine; degree of concern about HIV perceived severity of HIV and physical barriers to taking zidovudine. Logistic regression analysis (forward conditional entry) identified those who were having problems caking zidovudine and who were sceptical about its effectiveness, and ethnicity as significant independent predictors of compliance, correctly classifying 75% of cases (p < 0.01). The fact that subjects who have problems taking zidovudine or are sceptical about the value of zidovudine are less compliant, and that this dimension is a significant predictor of compliance, suggests that non-compliance is related to attitudes and beliefs about zidovudine. This is consistent with the HEM, which holds that the balance between barriers and benefits of a health-related behaviour are significant determinants of outcome.
引用
收藏
页码:439 / 447
页数:9
相关论文
共 50 条
  • [1] ZIDOVUDINE IN HIV-INFECTION
    GOTZSCHE, PC
    [J]. ANNALS OF MEDICINE, 1993, 25 (03) : 213 - 214
  • [2] ZIDOVUDINE FOR THE TREATMENT OF HIV-INFECTION
    PEPE, R
    MOLAVI, A
    [J]. AMERICAN FAMILY PHYSICIAN, 1990, 42 (02) : 437 - 443
  • [3] ZIDOVUDINE IN ASYMPTOMATIC HIV-INFECTION
    MARTINEZ, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (25): : 1895 - 1895
  • [4] EOSINOPHILS, HIV-INFECTION AND ZIDOVUDINE
    MCWHINNEY, PHM
    NATHWANI, D
    [J]. AIDS, 1990, 4 (08) : 817 - 817
  • [5] ZIDOVUDINE FOR SYMPTOMLESS HIV-INFECTION
    不详
    [J]. LANCET, 1990, 335 (8693): : 822 - 823
  • [6] ZIDOVUDINE IN ASYMPTOMATIC HIV-INFECTION
    HAMILTON, JD
    SIMBERKOFF, MS
    HARTIGAN, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (11): : 754 - 755
  • [7] EARLY ZIDOVUDINE AND SURVIVAL IN HIV-INFECTION
    HIRSCHEL, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (11): : 814 - 814
  • [8] ZIDOVUDINE FOR HIV-INFECTION WITHOUT SYMPTOMS
    KLEIN, RS
    [J]. LANCET, 1990, 335 (8699): : 1228 - 1228
  • [9] ZIDOVUDINE IN ASYMPTOMATIC HIV-INFECTION - REPLY
    VOLBERDING, PA
    LAGAKOS, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (11): : 756 - 756
  • [10] ZIDOVUDINE ABSORPTION IN CHILDREN WITH HIV-INFECTION
    KAUFFMAN, R
    COHEN, F
    MOORE, E
    ARAVIND, MK
    CRAIG, A
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) : 137 - 137